Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 1, 2004Clinical Transplantation

Early experience with two‐dose daclizumab in the prevention of acute rejection in cardiac transplantation

View Full Paper
Ask AI
Bookmark
Share

Authors

DJDominique JoyalJewish General HospitalMCMarcelo CantarovichMcGill University Health CentreRCRenzo CecereConference Board

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Joyal et al. (2004) studied this question.

synapsesocial.com/papers/6a93e87db476c202f20066f3https://doi.org/10.1111/j.1399-0012.2004.00189.x
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Review of Interleukin‐2 Receptor Antagonists in Solid Organ Transplantation1999 · 69 citations
  2. 2Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients2003 · 1,198 citations
  3. 3EXPRESSION OF TISSUE FACTOR IN HEPATIC ISCHEMIC-REPERFUSION INJURY OF THE RAT1998 · 33 citations
  4. 4SUCCESSFUL TRANSPLANTATION OF A LIVER GRAFT WITH A CALCIFIED HYDATID CYST AFTER BACK-TABLE RESECTION1995 · 33 citations
  5. 5PROLONGED ACTION OF A CHIMERIC INTERLEUKIN-2 RECEPTOR (CD25) MONOCLONAL ANTIBODY USED IN CADAVERIC RENAL TRANSPLANTATION1995 · 184 citations